Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Shelton DN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shelton DN; Digital Biology Group, Bio-Rad Laboratories, Pleasanton, California, United States of America., Bhagavatula P; Digital Biology Group, Bio-Rad Laboratories, Pleasanton, California, United States of America., Sepulveda N; Digital Biology Group, Bio-Rad Laboratories, Pleasanton, California, United States of America., Beppu L; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Gandhi S; Department of Pathology, Moffitt Cancer Center, Tampa, Florida, United States of America., Qin D; Department of Pathology, Moffitt Cancer Center, Tampa, Florida, United States of America., Hauenstein S; Digital Biology Group, Bio-Rad Laboratories, Pleasanton, California, United States of America., Radich J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Publikováno v:
PloS one [PLoS One] 2022 Mar 17; Vol. 17 (3), pp. e0265278. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
Autor:
Kruth KA; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA., Fang M; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA., Shelton DN; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA.; Bio-Rad Laboratories, Hercules, CA., Abu-Halawa O; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA.; Coe College, Cedar Rapids, IA., Mahling R; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA., Yang H; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA., Weissman JS; Department of Cellular and Molecular Pharmacology, University of California, San Francisco (UCSF), San Francisco, CA.; Howard Hughes Medical Institute, Chevy Chase, MD., Loh ML; Department of Pediatrics, Benioff Children's Hospital and.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA., Müschen M; Department of Pediatrics, Benioff Children's Hospital and.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA., Tasian SK; Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Bassik MC; Department of Genetics, School of Medicine, Stanford University, Stanford, CA; and., Kampmann M; Department of Biochemistry and Biophysics.; Institute for Neurodegenerative Diseases, and.; Chan-Zuckerberg Biohub, UCSF, San Francisco, CA., Pufall MA; Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA.
Publikováno v:
Blood [Blood] 2017 Jun 01; Vol. 129 (22), pp. 3000-3008. Date of Electronic Publication: 2017 Apr 19.
Autor:
Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang HJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fujii T; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shelton DN; Bio-Rad Laboratories, Pleasanton, CA, USA.; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA, USA., Madwani K; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wheler JJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zinner RG; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cabrilo G; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kopetz ES; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Luthra R; Hematopathology, Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kee BK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eng C; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Karlin-Neumann GA; Bio-Rad Laboratories, Pleasanton, CA, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Mar 01; Vol. 28 (3), pp. 642-650.
Autor:
Chang GA; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA., Tadepalli JS; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA., Shao Y; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA; Department of Population Health, New York University School of Medicine, New York, NY, USA., Zhang Y; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA; Department of Population Health, New York University School of Medicine, New York, NY, USA., Weiss S; Department of Medicine, Division of Oncology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA., Robinson E; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA., Spittle C; Molecular MD Corporation, Portland, OR, USA., Furtado M; Digital Biology Center, Bio-Rad Laboratories, Pleasanton, CA, USA., Shelton DN; Digital Biology Center, Bio-Rad Laboratories, Pleasanton, CA, USA., Karlin-Neumann G; Digital Biology Center, Bio-Rad Laboratories, Pleasanton, CA, USA., Pavlick A; Department of Medicine, Division of Oncology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA., Osman I; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA., Polsky D; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA. Electronic address: david.polsky@nyumc.org.
Publikováno v:
Molecular oncology [Mol Oncol] 2016 Jan; Vol. 10 (1), pp. 157-65. Date of Electronic Publication: 2015 Sep 25.
Autor:
Taylor SC; Bio-Rad Laboratories Canada, Inc., 1329 Meyerside Drive, Mississauga, ON, Canada L5T1C9. Electronic address: sean_taylor@bio-rad.com., Carbonneau J; CHU of Quebec and Laval University, Quebec City, QC, Canada., Shelton DN; Digital Biology Center, Bio-Rad Laboratories, Pleasanton, CA, USA., Boivin G; CHU of Quebec and Laval University, Quebec City, QC, Canada.
Publikováno v:
Journal of virological methods [J Virol Methods] 2015 Nov; Vol. 224, pp. 58-66. Date of Electronic Publication: 2015 Aug 24.
Autor:
Basham KJ; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., Leonard CJ; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., Kieffer C; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., Shelton DN; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., McDowell ME; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., Bhonde VR; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., Looper RE; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112., Welm BE; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112 *Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, Department of Chemistry, University of Utah, Salt Lake City, Utah 84112 and Department of Surgery, University of Utah, Salt Lake City, Utah 84112 bryan-welm@omrf.org.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2015 Jan; Vol. 143 (1), pp. 36-45. Date of Electronic Publication: 2014 Sep 29.